Motorola, Pfizer, Qualcomm Recommended on PBS's `Rukeyser'
By Vivien Lou Chen
Owings Mills, Maryland, Aug. 25 (Bloomberg) -- Motorola Inc., Pfizer Inc. and Qualcomm Inc. are companies worth investing in
as the U.S. stock market rallies, said a guest on ``Wall Street Week With Louis Rukeyser.''
``The bull is not dead, he's going to come back and probably come back fairly soon,'' said Charles Pradilla, chief investment
strategist for SG Cowen Securities Corp. ``But he's going to be a very different critter'' when it happens sometime next year, he
said.
Qualcomm, which licenses patents for mobile phones used by 90 million people, has an easy way to penetrate Third World
countries, Pradilla said on the PBS show. Pfizer, the biggest drugmaker, is a ``superb'' company that will benefit from changing
demographics, he added.
Motorola, the largest maker of chips for communications equipment, is a good turnaround bet as ``we near the end of this bear
market,'' he said. Its shares have dropped 47 percent in the past 12 months.
The slowing U.S. economy should rebound ``in the not too distant future'' because of the Federal Reserve's seventh interest-
rate cut of the year, federal tax rebates and continuing low inflation, Pradilla said.
Panelists on the show recommended companies including Enron Corp., the biggest energy trader; McKesson Corp., the second-
biggest U.S. drug wholesaler; and Mellon Financial Corp., which owns the Dreyfus family of mutual funds.
Other stocks recommended were energy trader Mirant Corp. and Northern Trust Corp., which provides banking and trust
services to the affluent. |
